CAMBRIDGE, Mass., Aug. 18, 2025 /PRNewswire/ — XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced that it will report its interim results for the six months ended June 30, 2025 on Wednesday, August 27, 2025, after the Hong Kong market closes.

The Company will hold a conference call in Chinese with English simultaneous interpretation at 7:00 PM Hong Kong/Beijing Time on August 27, 2025 (7:00 AM U.S. Eastern Time on the same day). Details for the conference call are as follows:

For Chinese original audio channel:

Online Registration Link: https://s.comein.cn/five6xyc

Alternatively, participants may access the conference call by dialing the following numbers:

Mainland China:

+86-4001510269

International:

+86-1021377168

Hong Kong, China:

+852-51089680

Taiwan, China:

+886-277083288

United States:

+1-2087016888

Password:

197788

The replay of the conference call will be available on the Company’s investor relations website at https://ir.xtalpi.com/en/investor-relations.

For English simultaneous interpretation channel:

Online Registration Link: https://s.comein.cn/s288yddg

About XtalPi

XtalPi Holdings Limited (XtalPi, 2228.HK) was founded in 2015 by three physicists from the Massachusetts Institute of Technology (MIT). It is an innovative R&D platform powered by quantum physics, artificial intelligence, and robotics. By integrating first-principles calculations, AI algorithms, high-performance cloud computing, and standardized automation systems, XtalPi provides digital and intelligent R&D solutions for companies in the pharmaceutical, materials science, agricultural technology, energy, new chemicals, and cosmetics industries.

Investor Relations Contact:

In China:

XtalPi Holdings LimitedInvestor RelationsEmail: ir@xtalpi.com

Piacente Financial CommunicationsTel: +86-10-6508-0677Email: XtalPi@thepiacentegroup.com

In the United States:

Piacente Financial CommunicationsBrandi PiacenteTel: +1-212-481-2050Email: XtalPi@thepiacentegroup.com

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Press Release Writing for Small Businesses: Tips and Strategies for Success

A press release is a reliable public relations tool for spreading a…

Facemoji Keyboard Uplevels AI Feature To Help Spark Connections

New Rizz Master boosts relationship acumen through customized dating prompts SUNNYVALE, Calif.,…

Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD)…